News

Wednesday March 27, 2019

27 Mar 2019 – MedPharm to develop new XF-drug formulations

Destiny Pharma plc (“Destiny Pharma” or “the Company”) Destiny Pharma appoints MedPharm to develop new XF‐platform drug formulations MedPharm will develop potential XF‐platform formulations as treatments for dermal and ocular […]

Friday March 22, 2019

22 Mar 2019 – Notice of Full Year Results

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT […]